Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-08

FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for dextroamphetamine sulfate from KVK-Tech, Inc., making the generic product available via an approved supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)